Johnson & Johnson (JNJ) and SNDL Inc. (SNDL) -- Buy or Sell?

NYSE: JNJ | Johnson & Johnson News, Ratings, and Charts

JNJ – Investing in healthcare stocks could help hedge against economic downturns. Thus, Johnson & Johnson (JNJ) could be worth buying. However, I think SNDL (SNDL) is best avoided considering its weak fundamentals. Read on…

Although healthcare stocks could help hedge some market risks, not all stocks are worth owning. While Johnson & Johnson (JNJ) could be an ideal buy, fundamentally weak SNDL Inc. (SNDL) might be best avoided.

Pharmaceutical companies are adopting digital technologies to streamline important, labor-intensive procedures. They are widely applied in the pharmaceutical value chain in several areas, including drug discovery and development, drug production, smart process automation, maximizing predictive maintenance, and supply chain management.

The global pharmaceutical industry is expected to be worth $1.57 trillion by 2023, driven by aging and growing population, rising income levels, and emerging medical conditions and new diseases.

However, on the other hand, the effects of the COVID-19 pandemic, as well as ongoing pressure from Russia’s invasion of Ukraine, dampened pharma investments.

Take a look at the stocks mentioned above:

Stock to Buy:

Johnson & Johnson (JNJ)

JNJ researches, develops, manufactures, and sells various products in the healthcare field worldwide.

On April 18, JNJ announced an quarterly cash dividend of $1.19 per share. The dividend is payable on June 6.

JNJ pays a $4.76 per share dividend annually, which translates to a 3% yield on the current price. Its dividend payments have grown at a CAGR of 5.9% over the past three years. The company has a four-year average dividend yield of 2.61%.

Its trailing-12-month asset turnover ratio of 0.51x is 45.4% higher than the 0.35x industry average. Its trailing-12-month EBITDA margin of 34.39% is significantly higher than the 1.79% industry average.

During the fiscal first quarter ended March 31, 2023, JNJ’s reported sales increased 5.6% year-over-year to $24.75 billion. Its adjusted net earnings came to $7.07 billion. Its adjusted earnings per share increased marginally year-over-year to $2.68.

JNJ’s revenue is expected to increase 2.7% year-over-year to $24.67 billion for the fiscal second quarter ending June 2023. The company’s EPS for the same quarter is expected to increase 1.1% year-over-year to $2.62.

Shares of JNJ have gained marginally intraday to close the last trading session at $157.72.

JNJ’s POWR Ratings reflect its promising outlook. The stock has an overall rating of A, which translates to a Strong Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.

It is ranked #6 out of 166 in the Medical – Pharmaceuticals industry.

Beyond what is stated above, we’ve also rated JNJ for Momentum. Get all JNJ ratings here.

Stock to Sell:


Headquartered in Calgary, Canada, SNDL engages in the production, distribution, and sale of cannabis products in Canada. The company operates through four segments: Liquor Retail; Cannabis Retail; Cannabis Operations; and Investments.

Its trailing-12-month gross profit margin of 19.71% is 64.7% lower than the 55.84% industry average. Its trailing-12-month Capex/Sales of 1.50% is 68.2% lower than the 4.70% industry average.

SDNL’s net revenue came to $240.41 million in the fiscal fourth quarter that ended December 31, 2023. Its net loss decreased 184.7% year-over-year to $161.57 million. Its adjusted EBITDA came in at negative $7.55 million, compared to $16.74 million in the previous-year quarter.

SNDL’s revenue is expected to come in at $733.04 million for the fiscal year ending December 2023. Also, it has failed to surpass EPS estimates in each of the trailing four quarters, which is disappointing.

The stock has declined 59.9% over the past year to close the last trading session at $1.76.

SNDL’s weak prospects are reflected in its POWR Ratings. The stock has an overall D rating, equating to a Sell in our proprietary rating system.

SNDL has a D grade for Stability and an F in Momentum. It is ranked #115 in the same industry.

Click here to see the additional POWR Ratings for SNDL (Sentiment, Growth, Value, and Quality).

What To Do Next?

Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today’s volatile markets:

3 Stocks to DOUBLE This Year >



JNJ shares were trading at $157.25 per share on Monday afternoon, down $1.66 (-1.04%). Year-to-date, JNJ has declined -10.34%, versus a 10.29% rise in the benchmark S&P 500 index during the same period.

About the Author: Nidhi Agarwal

Nidhi is passionate about the capital market and wealth management, which led her to pursue a career as an investment analyst. She holds a bachelor's degree in finance and marketing and is pursuing the CFA program. Her fundamental approach to analyzing stocks helps investors identify the best investment opportunities. More...

More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
JNJGet RatingGet RatingGet Rating
SNDLGet RatingGet RatingGet Rating

Most Popular Stories on

Is This REALLY a Bull Market?

The S&P 500 (SPY) keeps making record highs...but does that mean that market conditions are truly bullish? 44 year investment veteran shines a light on how hollow recent gains are as they are only accruing to a handful of stocks with most investors searching high and low for stock market gains. Read on for more...

Unveiling Adobe (ADBE) Q2 Earnings: What Lies Ahead for Investors?

Software giant Adobe Inc. (ADBE) has released its second-quarter earnings, revealing double-digit growth in both revenue and profits. Yet, concerns arise around the complexities of navigating growth in the face of advancing AI technologies. Let’s analyze ADBE’s recent performance and assess key fundamentals to uncover what lies ahead for investors…

3 AI Stocks to Invest in for the Next Technological Revolution

The AI market is experiencing a significant growth trajectory, driven by widespread application across various industries. Hence, it could be wise to invest in top AI stocks, Alphabet (GOOGL), Meta Platforms (META), and Alibaba Group Holding (BABA) for the next technological revolution. Read more...

Analyzing Broadcom’s (AVGO) Q2 Earnings: Worth Investing?

Driven by a surge in demand for its AI products, Broadcom (AVGO) reported robust earnings in its latest quarterly results, exceeding expectations on both top and bottom lines. However, is the stock’s recent announcement of a 10-for-1 stock split worth investing in? Keep reading to find out…

Bullish or Bearish Stock Set Up?

The S&P 500 (SPY) record highs sounds pretty darn bullish on the surface. Yet as we dig below the surface there are some curious signals that point more Risk Off. This is especially true as we come into the next Fed meeting after a round of data that points to inflation still being too high...only further delaying the first rate cut. What does this all mean for stocks from here? Steve Reitmeister offers his latest views on the market outlook along with a preview of his top picks to stay on step ahead of the market. Read on for more...

Read More Stories

More Johnson & Johnson (JNJ) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All JNJ News